Table 4 Post hoc comparisons for significant glm models predicting overexpression
From: Protein profiling of ovarian cancers by immunohistochemistry to identify potential target pathways
BCRP | ER | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Mean diff | SE | 95% LCL | 95% UCL | p | Mean diff | SE | 95% LCL | 95% UCL | p | ||
Carcinoma and serous | Clear cell | 0 | 0.08 | -0.16 | 0.16 | .993 | 0.33 | 0.08 | 0.17 | 0.49 | .000* |
Carcinoma and serous | Endometriod | 0.2 | 0.10 | 0.01 | 0.38 | .039 | -0.03 | 0.10 | -0.22 | 0.17 | .783 |
Carcinoma and serous | Other | 0.13 | 0.09 | -0.05 | 0.31 | .155 | 0.08 | 0.10 | -0.11 | 0.27 | .405 |
Clear cell | Endometriod | 0.2 | 0.12 | -0.04 | 0.44 | .110 | -0.36 | 0.12 | -0.60 | -0.12 | .003* |
Clear cell | Other | 0.13 | 0.12 | -0.11 | 0.37 | .279 | -0.25 | 0.12 | -0.48 | -0.02 | .037 |
Endometriod | Other | -0.07 | 0.13 | -0.32 | 0.19 | .609 | 0.11 | 0.13 | -0.15 | 0.37 | .417 |
MGMT | RRM1 | ||||||||||
Mean diff | SE | 95% LCL | 95% UCL | p | Mean diff | SE | 95% LCL | 95% UCL | p | ||
Carcinoma and serous | Clear cell | 0.31 | 0.11 | 0.10 | 0.52 | 0.00* | 0.33 | .081 | .17 | .49 | .000* |
Carcinoma and serous | Endometriod | 0.00 | 0.05 | -0.10 | 0.10 | 0.95 | 0.22 | .086 | .05 | .39 | .010* |
Carcinoma and serous | Other | 0.04 | 0.06 | -0.08 | 0.16 | 0.52 | -.10 | .097 | -.29 | .09 | .311 |
Clear cell | Endometriod | -0.31 | 0.12 | -0.54 | -0.08 | 0.00* | -.11 | .112 | -.33 | .11 | .338 |
Clear cell | Other | -0.27 | 0.12 | -0.51 | -0.04 | 0.02 | -0.43 | .121 | -.67 | -.19 | .000* |
Endometriod | Other | 0.04 | 0.08 | -0.11 | 0.18 | 0.95 | -0.32 | .124 | -.56 | -.08 | .010* |
PTEN | |||||||||||
Mean diff | SE | 95% LCL | 95% UCL | p | |||||||
Carcinoma and serous | Clear cell | .17 | .112 | -.05 | .39 | .128 | |||||
Carcinoma and serous | Endometriod | 0.22 | .097 | .03 | .41 | .024 | |||||
Carcinoma and serous | Other | .04 | .096 | -.15 | .23 | .679 | |||||
Clear cell | Endometriod | .05 | .144 | -.23 | .33 | .740 | |||||
Clear cell | Other | -.13 | .143 | -.41 | .15 | .359 | |||||
Endometriod | Other | -.18 | .131 | -.44 | .08 | .174 | |||||